<amendment session="118" chamber="h" number="295" updated="2024-03-14T12:53:16Z">
  <amends type="h" number="4366" sequence=""/>
  <status datetime="2023-07-26T15:48:42-04:00">pass</status>
  <sponsor bioguide_id="B001301"/>
  <offered datetime="2023-07-26"/>
  <description>An amendment numbered 24 printed in House Report 118-158 to increase and decrease the Medical and Prosthetic Research account at the Department of Veterans Affairs to ensure the VA conducts large-scale studies into the efficacy of drugs that have FDA-designated Breakthrough Therapy status to treat posttraumatic stress disorder through VA-administered drug assisted therapy trials.</description>
  <purpose/>
  <actions>
    <vote datetime="2023-07-26T15:48:42-04:00" how="by voice vote" result="pass">
      <text>On agreeing to the Bergman amendment (A005) Agreed to by voice vote.</text>
    </vote>
    <action datetime="2023-07-26T15:45:22-04:00">
      <text>Amendment (A005) offered by Mr. Bergman.</text>
      <reference ref="CR H3996" label="consideration"/>
      <reference ref="CR H3996" label="text"/>
    </action>
    <action datetime="2023-07-26">
      <text>House amendment offered</text>
    </action>
    <action datetime="2023-07-26T15:45:22-04:00">
      <text>House amendment offered/reported by: Amendment (A005) offered by Mr. Bergman.</text>
      <reference ref="CR H3996" label="consideration"/>
      <reference ref="CR H3996" label="text"/>
    </action>
    <action datetime="2023-07-26T15:48:42-04:00">
      <text>House amendment agreed to: On agreeing to the Bergman amendment (A005) Agreed to by voice vote.</text>
    </action>
    <action datetime="2023-07-26T15:48:42-04:00">
      <text>Amendment agreed to Committee of the Whole</text>
    </action>
  </actions>
</amendment>
